The advent of targeted cancer therapies has revolutionized oncology, yet the off-target effects of these agents on healthy cells remain a significant clinical challenge. Anemia is
Single-centre case series of 18 patients with descriptive outcomes and no comparator; generates mechanistic hypotheses about steatotic liver disease in allo-HSCT but lacks the control group and sample size needed to establish clinical impact.